Brimonidine Tartrate Api - Pharmaceutical Grade, 99% Purity, White To Off-white Powder, Hdpe Drum Packaging, Ir & Hplc Identified, Specific Optical Rotation +27 To +33

25 Kilograms/Kilograms

25 Kilograms/Kilograms

1 Kilograms/Kilograms,

0.001%

For Brimonidine Tartrate, as with most pharmaceutical compounds, the presence of heavy metals is typically monitored to ensure safety and compliance with pharmacological standards. The heavy metal content is generally tested and controlled according to pharmacopoeial standards (such as the USP or EP). The limit for heavy metals in pharmaceutical-grade Brimonidine Tartrate is typically set to 10 ppm (parts per million) or 10 g/g in the final product, depending on the specific regulations in place. This is done to ensure that any potential contaminants from metals like lead (Pb), arsenic (As), cadmium (Cd), or mercury (Hg) are kept well below toxic levels.

Present as per standards (Available upon request)

Brimonidine Base: 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine Tartrate Salt: (2R,3R)-2,3-dihydroxybutanedioic acid

90% 10 microns

The particle size of Brimonidine Tartrate can vary depending on the formulation and manufacturer.

Other, Store in a cool, dry place below 25C, protected from light

Room Temperature

230-240C (decomposes)

~205 C to 210 C (with decomposition)

36 months when properly stored

5 Years

Not applicable (decomposes before boiling)

The boiling point of Brimonidine Tartrate is not widely reported in standard references, as it tends to decompose before reaching its boiling point due to its complex chemical structure. Since it is used primarily in topical formulations and eye drops, it is typically not heated to the point where boiling would occur.

29334900

29333990

5-bromo-6-(2-imidazolidinylideneamino)quinoxaline tartrate

5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine tartrate (1:1)

Other, Active Pharmaceutical Ingredient (API)

Pharmaceutical Intermediates

Pharmaceutical Intermediates

Used in the treatment of open-angle glaucoma and ocular hypertension

Brimonidine Tartrate is primarily used in ophthalmology and dermatology for the following purposes:1. Glaucoma and Ocular HypertensionMechanism: It is an alpha-2 adrenergic receptor agonist.Action: Reduces intraocular pressure (IOP) by decreasing aqueous humor production and increasing uveoscleral outflow.Brand names: Commonly found in products like Alphagan .2. Facial Redness in RosaceaMechanism: Causes vasoconstriction of dilated facial blood vessels.Form: Typically used as a topical gel or cream.Brand names: Examples include Mirvaso .

White to off-white powder

White to off-white crystalline powder It is usually odorless and freely soluble in water and methanol, but less soluble in non-polar solvents.

Cash on Delivery (COD), Cash in Advance (CID), Cash Against Delivery (CAD)

Letter of Credit at Sight (Sight L/C), Letter of Credit (L/C), Cash Advance (CA), Cash in Advance (CID)

5-7 Days

7 Days

1 Days

160000.0 INR (Approx.)

180000 INR (Approx.)